Publications by authors named "Sydney Grant"

Actinic keratoses (AKs) and keratinocyte carcinomas (KCs) arise from prolonged UV exposure, with precursor UV-induced clonal mutations (CMs) appearing in sun-damaged skin. Photodynamic therapy (PDT) is a common field treatment for AKs and early KCs, but its impact on subclinical CMs is unknown. This study examines CMs using targeted ultra-deep sequencing on epidermal samples.

View Article and Find Full Text PDF

More than 80,000 new cases of bladder cancer are estimated to be diagnosed in 2023. However, the 5-year survival rate for bladder cancer has not changed in decades, highlighting the need for prevention. Numerous cancer-causing mutations are present in the urothelium long before signs of cancer arise.

View Article and Find Full Text PDF

Mutations found in skin are acquired in specific patterns, clustering around mutation-prone genomic locations. The most mutation-prone genomic areas, mutation hotspots, first induce the growth of small cell clones in healthy skin. Mutations accumulate over time, and clones with driver mutations may give rise to skin cancer.

View Article and Find Full Text PDF

Melanoma is among the most devastating human malignancies. Accurate diagnosis and prognosis are essential to offer optimal treatment. Histopathology is the gold standard for establishing melanoma diagnosis and prognostic features.

View Article and Find Full Text PDF
Article Synopsis
  • Radiomics is emerging in radiology research, focusing on using ML/AI to analyze complex imaging features from ultrasound in head and neck cancers.
  • A comprehensive review analyzed 34 studies from a pool of over 15,000, primarily highlighting the diagnostic value of ultrasound radiomics, with support vector machines being the most common AI method used.
  • Although the majority of studies had limitations like being retrospective or single-center, they showed that ML methods could significantly enhance the diagnostic and prognostic accuracy of ultrasound imaging in clinical settings.
View Article and Find Full Text PDF

Patients with metastatic breast cancer (MBC) have limited therapeutic options and novel treatments are critically needed. Prior research implicates tumor-induced mobilization of myeloid cell populations in metastatic progression, as well as being an unfavorable outcome in MBC; however, the underlying mechanisms for these relationships remain unknown. Here, we provide evidence for a novel mechanism by which p38 promotes metastasis.

View Article and Find Full Text PDF